299 related articles for article (PubMed ID: 29893658)
1. A retrospective analysis of adverse events among patients receiving daptomycin versus vancomycin during outpatient parenteral antimicrobial therapy.
Schrank GM; Wright SB; Branch-Elliman W; LaSalvia MT
Infect Control Hosp Epidemiol; 2018 Aug; 39(8):947-954. PubMed ID: 29893658
[TBL] [Abstract][Full Text] [Related]
2. Adverse events, healthcare interventions and healthcare utilization during home infusion therapy with daptomycin and vancomycin: a propensity score-matched cohort study.
Shrestha NK; Mason P; Gordon SM; Neuner E; Nutter B; O'Rourke C; Rehm SJ
J Antimicrob Chemother; 2014 May; 69(5):1407-15. PubMed ID: 24398341
[TBL] [Abstract][Full Text] [Related]
3. Rates of and Risk Factors for Adverse Drug Events in Outpatient Parenteral Antimicrobial Therapy.
Keller SC; Williams D; Gavgani M; Hirsch D; Adamovich J; Hohl D; Gurses AP; Cosgrove SE
Clin Infect Dis; 2018 Jan; 66(1):11-19. PubMed ID: 29020202
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of outpatient parenteral antibiotic therapy in an academic infectious disease clinic.
Suleyman G; Kenney R; Zervos MJ; Weinmann A
J Clin Pharm Ther; 2017 Feb; 42(1):39-43. PubMed ID: 27747899
[TBL] [Abstract][Full Text] [Related]
5. More Frequent Premature Antibiotic Discontinuations and Acute Kidney Injury in the Outpatient Setting With Vancomycin Compared to Daptomycin.
Tuerff D; Nunez M
J Clin Pharmacol; 2020 Mar; 60(3):384-390. PubMed ID: 31630403
[TBL] [Abstract][Full Text] [Related]
6. Comparison of dalbavancin to standard-of-care for outpatient treatment of invasive Gram-positive infections.
Veve MP; Patel N; Smith ZA; Yeager SD; Wright LR; Shorman MA
Int J Antimicrob Agents; 2020 Dec; 56(6):106210. PubMed ID: 33223119
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of daptomycin in outpatient parenteral antimicrobial therapy: a prospective and multicenter cohort study (DAPTODOM trial).
Cervera C; Sanroma P; González-Ramallo V; García de la María C; Sanclemente G; Sopena N; Pajarón M; Segado A; Mirón M; Antón F; Basterretxea A; Cuende A; Miró JM;
Infect Dis (Lond); 2017 Mar; 49(3):200-207. PubMed ID: 27820968
[TBL] [Abstract][Full Text] [Related]
8. Comparative Effectiveness of Vancomycin Versus Daptomycin for MRSA Bacteremia With Vancomycin MIC >1 mg/L: A Multicenter Evaluation.
Moise PA; Culshaw DL; Wong-Beringer A; Bensman J; Lamp KC; Smith WJ; Bauer K; Goff DA; Adamson R; Leuthner K; Virata MD; McKinnell JA; Chaudhry SB; Eskandarian R; Lodise T; Reyes K; Zervos MJ
Clin Ther; 2016 Jan; 38(1):16-30. PubMed ID: 26585355
[TBL] [Abstract][Full Text] [Related]
9. Acute kidney injury during daptomycin versus vancomycin treatment in cardiovascular critically ill patients: a propensity score matched analysis.
Gaudard P; Saour M; Morquin D; David H; Eliet J; Villiet M; Daures JP; Colson P
BMC Infect Dis; 2019 May; 19(1):438. PubMed ID: 31109283
[TBL] [Abstract][Full Text] [Related]
10. Daptomycin therapy for vancomycin-resistant enterococcal bacteremia: a retrospective case series of 30 patients.
Gallagher JC; Perez ME; Marino EA; LoCastro LG; Abrardo LA; MacDougall C
Pharmacotherapy; 2009 Jul; 29(7):792-9. PubMed ID: 19558253
[TBL] [Abstract][Full Text] [Related]
11. Daptomycin Improves Outcomes Regardless of Vancomycin MIC in a Propensity-Matched Analysis of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.
Claeys KC; Zasowski EJ; Casapao AM; Lagnf AM; Nagel JL; Nguyen CT; Hallesy JA; Compton MT; Kaye KS; Levine DP; Davis SL; Rybak MJ
Antimicrob Agents Chemother; 2016 Oct; 60(10):5841-8. PubMed ID: 27431221
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for readmission among patients receiving outpatient parenteral antimicrobial therapy: a retrospective cohort study.
Douiyeb S; de la Court JR; Tuinte B; Sombogaard F; Schade RP; Kuijvenhoven M; Minderhoud T; Sigaloff KCE
Int J Clin Pharm; 2022 Apr; 44(2):557-563. PubMed ID: 35157228
[TBL] [Abstract][Full Text] [Related]
13. Comparative outcomes of β-lactam antibiotics in outpatient parenteral antibiotic therapy: treatment success, readmissions and antibiotic switches.
Lee B; Tam I; Weigel B; Breeze JL; Paulus JK; Nelson J; Allison GM
J Antimicrob Chemother; 2015 Aug; 70(8):2389-96. PubMed ID: 26024869
[TBL] [Abstract][Full Text] [Related]
14. Outpatient parenteral antibiotic therapy with daptomycin: insights from a patient registry.
Martone WJ; Lindfield KC; Katz DE
Int J Clin Pract; 2008 Aug; 62(8):1183-7. PubMed ID: 18705821
[TBL] [Abstract][Full Text] [Related]
15. Clinical Outcomes of Daptomycin for Vancomycin-resistant Enterococcus Bacteremia.
Moise PA; Sakoulas G; McKinnell JA; Lamp KC; DePestel DD; Yoon MJ; Reyes K; Zervos MJ
Clin Ther; 2015 Jul; 37(7):1443-1453.e2. PubMed ID: 25982687
[TBL] [Abstract][Full Text] [Related]
16. Daptomycin compared to vancomycin for the treatment of osteomyelitis: a single-center, retrospective cohort study.
Moenster RP; Linneman TW; Finnegan PM; McDonald JR
Clin Ther; 2012 Jul; 34(7):1521-7. PubMed ID: 22748973
[TBL] [Abstract][Full Text] [Related]
17. Nephrotoxicity Risk and Clinical Effectiveness of Continuous versus Intermittent Infusion Vancomycin Among Patients in an Outpatient Parenteral Antimicrobial Therapy Program.
Shakeraneh P; Fazili T; Wang D; Gilotra T; Steele JM; Seabury RW; Miller CD; Darko W; Probst LA; Kufel WD
Pharmacotherapy; 2020 Apr; 40(4):357-362. PubMed ID: 32090347
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the Effectiveness and Safety of Linezolid and Daptomycin in Vancomycin-Resistant Enterococcal Bloodstream Infection: A National Cohort Study of Veterans Affairs Patients.
Britt NS; Potter EM; Patel N; Steed ME
Clin Infect Dis; 2015 Sep; 61(6):871-8. PubMed ID: 26063715
[TBL] [Abstract][Full Text] [Related]
19. Effect of Continuous and Sequential Therapy among Veterans Receiving Daptomycin or Linezolid for Vancomycin-Resistant Enterococcus faecium Bacteremia.
Britt NS; Potter EM; Patel N; Steed ME
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28264856
[TBL] [Abstract][Full Text] [Related]
20. Outpatient treatment of osteomyelitis with telavancin.
Schroeder CP; Van Anglen LJ; Dretler RH; Adams JS; Prokesch RC; Luu Q; Krinsky AH
Int J Antimicrob Agents; 2017 Jul; 50(1):93-96. PubMed ID: 28456704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
